Sale!

AFG3L2 Gene Spastic Ataxia Type 5 Autosomal Recessive Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AFG3L2 gene plays a critical role in the proper functioning of the human nervous system. Mutations in this gene are associated with Spastic Ataxia Type 5, an autosomal recessive neurological disorder. This condition is characterized by a combination of spasticity and ataxia, which are, respectively, muscle stiffness and a lack of muscle control that leads to speech and movement difficulties. Due to its genetic basis, identifying carriers or affected individuals early can be crucial for management and counseling.

DNA Labs UAE offers a specialized genetic test targeting the AFG3L2 gene to identify mutations that may lead to Spastic Ataxia Type 5. This test is a vital tool for individuals with a family history of the condition or who are experiencing symptoms related to the disorder. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for specific mutations in the AFG3L2 gene.

The cost of the AFG3L2 gene test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides for affected individuals and their families is immeasurable. It not only aids in the diagnosis of Spastic Ataxia Type 5 but also helps in making informed decisions regarding family planning and management of the disorder. With the test available at DNA Labs UAE, individuals have access to critical genetic information that can significantly impact their health management and quality of life.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AFG3L2 Gene Spastic Ataxia Type 5 Autosomal Recessive Genetic Test

Are you concerned about the possibility of having spastic ataxia type 5? DNA Labs UAE offers a comprehensive genetic test to determine if you carry the AFG3L2 gene mutation associated with this condition.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the AFG3L2 gene spastic ataxia type 5 genetic test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by this autosomal recessive condition.

Test Details

AFG3L2 gene spastic ataxia type 5 is a genetic disorder that is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated AFG3L2 gene, one from each parent, in order to develop the condition.

To confirm a diagnosis of spastic ataxia type 5, a genetic test using Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. It can identify mutations or variations in the AFG3L2 gene that are associated with spastic ataxia type 5.

The NGS genetic test for spastic ataxia type 5 typically involves obtaining a blood or saliva sample from the individual being tested. The DNA in the sample is then sequenced using NGS technology to identify any mutations or variations in the AFG3L2 gene.

The results of the test can help confirm a diagnosis of spastic ataxia type 5 and provide valuable information for genetic counseling and management of the condition.

It is important to note that genetic testing for spastic ataxia type 5 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Name AFG3L2 Gene Spastic ataxia type 5 autosomal recessive Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for AFG3L2 Gene Spastic ataxia type 5, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with AFG3L2 Gene Spastic ataxia type 5, autosomal recessive
Test Details

AFG3L2 gene spastic ataxia type 5 is a genetic disorder that is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated AFG3L2 gene, one from each parent, in order to develop the condition.

To confirm a diagnosis of spastic ataxia type 5, a genetic test using Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. It can identify mutations or variations in the AFG3L2 gene that are associated with spastic ataxia type 5.

The NGS genetic test for spastic ataxia type 5 typically involves obtaining a blood or saliva sample from the individual being tested. The DNA in the sample is then sequenced using NGS technology to identify any mutations or variations in the AFG3L2 gene. The results of the test can help confirm a diagnosis of spastic ataxia type 5 and provide valuable information for genetic counseling and management of the condition.

It is important to note that genetic testing for spastic ataxia type 5 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.